Should You Buy Bristol Myers Squibb Stock Right Now for the Yield Alone?
As management tackles key issues head-on, Bristol Myers Squibb stock offers a steady 4% yield, with further upside potential.
Thursday, October 15, 2026
8,379 stories
As management tackles key issues head-on, Bristol Myers Squibb stock offers a steady 4% yield, with further upside potential.
Shares of DraftKings Inc. (NASDAQ:DKNG) and Flutter Entertainment plc (NYSE:FLUT) soared on August 28 after the Ninth Circuit Court of Appeals ruled that spo...
A year-over-year decline in aircraft deliveries last month doesn't tell Boeing's entire story.
Brian Chesky made a bold claim at Goldman Sachs this week, comparing AI to electricity and calling it the best thing to ever happen to Airbnb. The real quest...
Getting laid off at 62 means the safety nets are close but not close enough, and the gap between now and Social Security has to be funded somehow. Here is on...
Exchange-traded funds are a low-cost way to get diversified exposure to investments, freeing you up to focus on what you do best.
Boston Scientific Corporation (NYSE:BSX) fell 2.3% in early trading on September 8, 2026, after disclosing that an August 25 cyberattack disrupted manufactur...
This stock has jumped 68% over the past year.
After spending years trading like a premium-priced AI leader, Nvidia may now be among the cheapest names in Piper Sandler’s AI universe. NVIDIA Corporation (...
JPMorgan cut its Adobe stock price target to $315 from $340, but kept an Overweight rating, calling the shares cheap ahead of a monetization recovery.
This actively managed exchange-traded fund is producing spectacular returns for investors thanks to its unique strategy.
Starbucks Corporation (NASDAQ:SBUX) is betting $1 billion that leather armchairs, rugs, and bookshelves can turn a recovering coffee business into a more pro...
The company's own forecast leaves room to miss the milestone. I don't expect that to happen.
The safety of government-guaranteed bonds is compelling to be sure. There are just a couple of nagging drawbacks that I can't live with. Maybe you can.
Two investment giants point to the same year-end stock move
Target's dividend streak just hit another milestone, but income investors focused on the checkmark may be missing the detail buried in the numbers that chang...
Google just landed inside nearly every major Fortune 100 company, but having access and winning the deal are two very different things. The real fight is hap...
Past reputations can cloud investor judgments when analyzing a stock.